29.4.2016   

HR

Službeni list Europske unije

C 154/1


Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. ožujka 2016. do 31. ožujka 2016.

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))

(2016/C 154/01)

—   Izdavanje odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

INN (medunarodni nezašticeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

16.3.2016.

Coagadex

ljudskog koagulacijskog faktora X

Bio Products Laboratory Ltd

Dagger Lane, Elstree, Hertfordshire WD6 3BX, United Kingdom

EU/1/16/1087

Prašak i otapalo za otopinu za injekciju

B02BD13

18.3.2016.

16.3.2016.

Neofordex

Deksametazon

Laboratoires CTRS

63 rue de l’Est, F-92100 Boulogne-Billancourt, France

EU/1/15/1053

Tableta

H02AB02

18.3.2016.

22.3.2016.

Amlodipin/Valsartan Mylan

Amlodipin/Valsartan

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/16/1092

Filmom obložena tableta

C09DB01

29.3.2016.

31.3.2016.

Wakix

pitolizantklorida

Bioprojet Pharma

9 rue Rameau, F-75002 Pariz, France

EU/1/15/1068

Filmom obložena tableta

N07XX11

4.4.2016.

31.3.2016.

Zonisamide Mylan

zonisamida

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/16/1093

Kapsula, tvrda

N03AX15

4.4.2016.

—   Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

2.3.2016.

Copalia

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/06/372

4.3.2016.

2.3.2016.

Dafiro

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/06/371

4.3.2016.

2.3.2016.

DuoPlavin

Sanofi Clir SNC

54 rue La Boétie, F-75008 Pariz, France

EU/1/10/619

7.3.2016.

2.3.2016.

Efavirenz Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/742

4.3.2016.

2.3.2016.

Exforge HCT

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/09/569

4.3.2016.

2.3.2016.

Faslodex

AstraZeneca UK Limited

Alderley Park, Macclesfield, Cheshire, SK10 4TG United Kingdom

EU/1/03/269

4.3.2016.

2.3.2016.

Jentadueto

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/12/780

7.3.2016.

2.3.2016.

Menveo

GSK Vaccines S.r.l.

Via Fiorentina, 1, IT-53100 Siena, Italia

EU/1/10/614

4.3.2016.

2.3.2016.

Mozobil

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/09/537

4.3.2016.

2.3.2016.

Xydalba

Durata Therapeutics International B.V.

Spaces Zuidas II, Barbara Strozzilaan 101, 1083 HN Amsterdam, Nederland

EU/1/14/986

4.3.2016.

7.3.2016.

Avamys

Glaxo Group Ltd

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

EU/1/07/434

9.3.2016.

7.3.2016.

Dacogen

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/12/792

9.3.2016.

7.3.2016.

Signifor

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/12/753

9.3.2016.

7.3.2016.

Triumeq

ViiV Healthcare UK Limited

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom

EU/1/14/940

9.3.2016.

10.3.2016.

Celsentri

ViiV Healthcare UK Limited

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom

EU/1/07/418

14.3.2016.

10.3.2016.

Onglyza

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/09/545

14.3.2016.

11.3.2016.

Deltyba

Otsuka Novel Products GmbH

Erika-Mann-Straße 21, D-80636 München, Deutschland

EU/1/13/875

16.3.2016.

11.3.2016.

Savene

Clinigen Healthcare Limited

Pitcairn House, Crown Square, First Avenue, Burton-on-Trent, Staffordshire DE14 2WW, United Kingdom

EU/1/06/350

16.3.2016.

11.3.2016.

Topotecan Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/09/552

16.3.2016.

16.3.2016.

Cuprymina

SPARKLE S.r.l.

Località Cavallino, 62010 Montecosaro (MC), Italia

EU/1/12/784

21.3.2016.

22.3.2016.

Copalia HCT

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/09/575

29.3.2016.

22.3.2016.

Exforge

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/06/370

29.3.2016.

22.3.2016.

Exjade

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/06/356

29.3.2016.

22.3.2016.

Iclusig

ARIAD Pharma Ltd

Riverbridge House, Guildford Road, Leatherhead, Surrey KT22 9AD, United Kingdom

EU/1/13/839

29.3.2016.

22.3.2016.

Kepivance

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm, Sverige

EU/1/05/314

29.3.2016.

22.3.2016.

Laventair

Glaxo Group Ltd

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

EU/1/14/899

29.3.2016.

22.3.2016.

Mekinist

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/14/931

29.3.2016.

22.3.2016.

Pixuvri

CTI Life Sciences Ltd

Highlands House, Basingstoke Road, Spencers Wood, Reading, Berkshire RG7 1NT, United Kingdom

EU/1/12/764

29.3.2016.

22.3.2016.

Trajenta

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/11/707

29.3.2016.

22.3.2016.

Zykadia

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/15/999

29.3.2016.

23.3.2016.

Elocta

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm, Sverige

EU/1/15/1046

30.3.2016.

30.3.2016.

Abseamed

Medice Arzneimittel Pütter GmbH & Co KG

Kuhloweg 37, D-58638 Iserlohn, Deutschland

EU/1/07/412

1.4.2016.

30.3.2016.

Anoro

Glaxo Group Ltd

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

EU/1/14/898

1.4.2016.

30.3.2016.

Evra

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/02/223

1.4.2016.

30.3.2016.

TachoSil

Takeda Austria GmbH

St.-Peter-Strasse 25, A-4020 Linz, Österreich

EU/1/04/277

1.4.2016.

30.3.2016.

Vidaza

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge UB11 1DB, United Kingdom

EU/1/08/488

1.4.2016.

31.3.2016.

Betmiga

Astellas Pharma Europe B.V.

Sylviusweg 62, NL-2333 BE Leiden, Nederland

EU/1/12/809

4.4.2016.

31.3.2016.

Binocrit

Sandoz GmbH

Biochemiestrasse 10, A-6250 Kundl, Österreich

EU/1/07/410

4.4.2016.

31.3.2016.

Caelyx

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/96/011

4.4.2016.

31.3.2016.

Capecitabine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/761

4.4.2016.

31.3.2016.

Ecansya

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/12/763

4.4.2016.

31.3.2016.

Epoetin alfa Hexal

Hexal AG

Industriestrasse 25, D-83607 Holzkirchen, Deutschland

EU/1/07/411

4.4.2016.

31.3.2016.

Eviplera

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/11/737

4.4.2016.

31.3.2016.

Giotrif

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/13/879

4.4.2016.

31.3.2016.

Lynparza

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/959

4.4.2016.

31.3.2016.

Revatio

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/05/318

4.4.2016.

31.3.2016.

Ruconest

Pharming Group N.V.

Darwinweg 24, NL-2333 CR Leiden, Nederland

EU/1/10/641

4.4.2016.

31.3.2016.

Vargatef

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/14/954

4.4.2016.

—   Povlačenje odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

2.3.2016.

Nuedexta

Jenson Pharmaceutical Services Ltd

Carradine House 237 Regents Park Road, London N3 3LF, United Kingdom

EU/1/13/833

4.3.2016.

—   Obustava odobrenja za stavljanje u promet (članak 20. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

23.3.2016.

Zydelig

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/14/938

30.3.2016.

—   Izmjena odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

8.3.2016.

Palladia

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/09/100

10.3.2016.

15.3.2016.

BLUEVAC BTV8

CZ Veterinaria, S.A.

La Relva s/n, 36400 Porriño, España

EU/2/11/122

17.3.2016.

15.3.2016.

Versican Plus DHPPi

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/169

17.3.2016.

15.3.2016.

Versican Plus DHPPi/L4

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/164

17.3.2016.

15.3.2016.

Versican Plus DHPPi/L4R

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/163

17.3.2016.

Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

European Medicines Agency

30 Churchill Place

Canary Wharf

London E14 5EU

United Kingdom


(1)  SL L 136, 30.4.2004., str. 1.